The lowest effective dose of botulinum A toxin in adult patients with upper limb spasticity

References

• Gowland C. Management of hemiplegic upper limb. In: Branstater ME, Basmajian JV, editors. Stroke rehabiltation. Baltimore, MD: Williams and Wilkins 1987; pp. 217–245.
   Google Scholar
• Katrak PH, Cole AMD, Poulos CJ, McCauley JCK. Objective assessment of spasticity, strength and function with early exhibition of dantrolene sodium after cerebro-vascular accident: a randomised, double-blind study. Arch Phy Med Rehabil 1992;73: 4– 9.
   Google Scholar
• Bakheit AMO, Badwan DAH, McLellan DL. The effective- ness of chemical neurolysis in the treatment of lower limb muscle spaticity. Clin Rehabil 1996; 61: 30–35.
   Google Scholar
• Bhakta BB, Conzens JA, Bamford JM, Chamberlaim MA. Use of botulinum toxin in stroke patients with server upper limb spasticity. J Neurol Neurosurg Psychiatry 1996; 61(1):30–35.
   Google Scholar
• Hesse S, Reiter F, Konrad M, Jahnke MT. Botulinum toxin type A and short-term electrical stimulation in the treatment of upper limb flexor spasticity after stroke: a randomized, double-blind, placebo-controlled trial. Clin Rehabil 1998; 12: 81–88.
   Google Scholar
• Simpson DM, Alexander DN, O’Bien CF, Tagliati M, Aswad AS, Leon JM, Gibson J, Mordaunt JM, Monaghann EP. Botulinum toxin type A in the treatment of upper extremity spasticity: a randomized, double-blind, placebo-controlled trial. Neurology 1996; 46(5):1306–1310.
   Google Scholar
• Aoki KR. Pharmacology and immunology of botulinum toxin serotypes. J Neurol 2001;248 (Suppl 1):1/3–1/10.
   Google Scholar
• Bakheit AMO, Thilmann AF, Ward AB, et al. A randomized, double-blind, placebo-controlled, dose-ranging study to com- pare the efficacy and safety of three doses of botulinum toxin type A (Dysport1) with placebo in upper limb spasticity after stroke Stroke 2000; 31: 2402–2406.
   Google Scholar
• Brashear A, Gordon MF, Elovic E, et al. Botox1 Post stroke Study Group. A multicenter, double-blind, randomized, placebo-controlled, pararell study of the safety and efficacy of Botox1 (Botulinum Toxin Type A) Purified Neurotoxin in the treatment of focal upper limb spasticity poststroke. Neurology 2001;56 (Suppl 3): A78.
   Google Scholar
• Panizza M, Castagna M, di Summa A, Saibene L, Grioni G, Nilsson J. Functional and clinical changes in upper limb spastic patients treated with botulinum toxin (BTX). Funct Neurol 2000; 15(3):147–155.
   Google Scholar
• Bakheit AM, Pittock S, Moore AP, Wurker M, Otto S, Erbguth F, Coxon L.A randomized, double-blind, placebo- controlled study of the efficacy and safety of botulinum toxin type A in upper limb spasticity in patients with stroke. Eur J Neurol 2001; 8(6):559–565.
   Google Scholar
• Bhakta BB, Cozens JA, Chamberlain MA, Bamford JM. Impact of botulinum toxin type A on disability and career burden due to arm spasticity after stroke: a randomised double blind placebo controlled trial. J Neurol Neurosurg Psychiatry 2000; 69(2):217–221.
   Google Scholar
• Lagalla G, Danni M, Reiter F, Ceravolo MG, Provinciali L. Post-stroke spasticity management with repeated botulinum toxin injections in the upper limb. Am J Phys Med Rehabil 2000; 79(4):377–384; quiz 391–394.
   Google Scholar
• Hesse S, Reiter F, Konrad M, Jahnke MT. Botulinum toxin type A and short-term electrical stimulation in the treatment of upper limb flexor spasticity after stroke: a randomized, double-blind, placebo-controlled trial. Clin Rehabil 1998; 12(5):381–388.
   Google Scholar
• Pavesi G, Brianti R, Medici D, Mammi P, Mazzucchi A, Mancia D. Botulinum toxin type A in the treatment of upper limb spasticity among patients with traumatic brain injury. J Neurol Neurosurg Psychiatry 1998; 64(3):419–420.
   Google Scholar
• Corry IS, Cosgrove AP, Walsh EG, McClean D, Graham HK. Botulinum toxin A in the hemiplegic upper limb: a double- blind trial. Dev Med Child Neurol 1997; 39(3):185–193.
   Google Scholar
• Sampaio C, Ferreira JJ, Pinto AA, Crespo M, Ferro JM, Castro-Caldas A. Botulinum toxin type A for the treatment of arm and hand spasticity in stroke patients. Clin Rehabil 1997; 11(1):3–7.
   PubMed Web of Science ®Google Scholar
• Smith SJ, Ellis E, White S, Moore AP. A double-blind placebo-controlled study of botulinum toxin in upper limb spasticity after stroke or head injury. Clin Rehabil 2000;14: 5– 13.
   Google Scholar
• Wang HC, Hsieh LF, Chi WC, Lou SM. Effect of intramuscular botulinum toxin injection on upper limb spasticity in stroke patients. Am J Phys Med Rehabil 2002; 81: 272–278.
   Google Scholar
• Brashear A, Gordon MF, Elovic E, et al. BOTOX1 Post stroke Study Group. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after stroke. New Engl J Med 2002; 347: 395–400.
   Google Scholar
• Suputtitada A. Managing spasticity in pediatric cerebral palsy using a very low dose of botulinum toxin type A: Preliminary report. Am J Phys Med Rehabil 2000; 320–326.
   Google Scholar
• Suputtitada A. Three case reports of using botulinum toxin type A in chronic myofascial pain syndromes. J Thai Rehabil 2001; 11(1):35–41.
   Google Scholar
• Suputtitada A. Cervical spondylosis and myelopathy in cervical dystonia. In: Peek WJ, Lankhorst CJ, editors. Proceedings of the 1st World Congress of the International Society of Physical and Rehabilitation Medicine(1stISPRM) at Amsterdam, The Netherlands, July 7 – 13, 2001.
   Google Scholar
• Suputtitada A. Local botulinum toxin type A injection in the treatment of spastic toes. Am J Phys Med Rehabil 2002;81: 770– 775.
   Google Scholar
• Suputtitada A, Phanthumchinda K, Locharernkul C, Suwan- wela NC. Treatment of writer’s cramp with very low dose botulinum toxin type A at King Chulalongkorn Memorial Hospital. Proceedings of the International Conference 2002:Basic and Therapeutic Aspects of Botulinum and Tetanus Toxins at Hannover, Germany on June 8 – 11, 2002. Abstract published in N-S Arch Pharmacol 2002;148 (Suppl 2):365.
   Google Scholar
• Suputtitada A. Effectiveness of low dose botulinum toxin in spastic adult patients. In: Ring H, Soroker N, editors. Proceedings of the 2nd World Congress of the International Society of Physical and Rehabilitation Medicine (2nd ISPRM) at Prague, Czech Republic, May 18 – 22, 2003.
   Google Scholar
• Bohannon RW, Smith MB. Interater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther 1987; 67: 206–207.
   Google Scholar
• Lyle RC. A performance test for assessment of upper limb function in physical rehabilitation treatment and research. Int J Rehabil Res 1981; 4: 483–492.
   Google Scholar
• Collin C, Wade DT, Davis S, Horne V. The Barthel ADL Index: reliability study. Int Disabil Stud 1988; 10: 61–63.
   Google Scholar
• Brin MF. Patient visit forms and rating scales. Muscle Nerve 1997;20 (Suppl 6): Appendix.
   Google Scholar
• Eleopra R, Tugnoli V, De Grandis D. The variability in the clinical effect induced by botulinum toxin A: the role of muscle activity in humans. Mov Disord 1997; 12: 89–94.
   Google Scholar
• Hesse S, Jahnke MT, Luecke D, Mauritz KH. Short-term electrical stimulation enhance the effectiveness of botulinum toxin in the treatment of lower limb spasticity in hemiparetic patients. Neurosci Lett 1995; 201: 37–40.
   Google Scholar
• Hesse S, Reiter F, Konrad M, Jahnke MT. Botulinum toxin type A and short-term electrical stimulation in the treatment of upper limb flexor spasticity after stroke: a randomized, double-blind, placebo-controlled trial. Clin Rehabil 1998; 12: 81–88.
   Google Scholar
• Reiter F, Danni M, Lagalla G, Ceravolo G, Provinciali L. Low dose botulinum toxin with ankle taping for the treatment of spastic equinovarus foot after stroke. Arch Phy Med Rehabil 1998; 79: 532–535.
   Google Scholar
• Finsterer J, Fuchs I, Mamoli B. Automatic guided botulinum toxin treatment of spasticity. Clin Neuropharmacol 1997;3: 195– 203.
   Google Scholar